期刊文献+

苦碟子联合华佗再造丸治疗脑梗死疗效观察 被引量:2

Curative Effect with Ku Dei Zi Plus Hua Tuo Recreative pills Therapy in Cerebral Infarction
下载PDF
导出
摘要 探讨苦碟子联合华佗再造丸治疗脑梗死的临床疗效安全性.将150例脑梗死的病人(头颅CT证实)随机分成治疗组和对照组,治疗组为74例,对照组为76例.对照组采用常规治疗,治疗组在对照组的基础上给予华佗再造丸加苦碟子治疗.两组均给予阿司匹林和脑保护剂.治疗两周即一个疗程后观察两组临床疗效和药物反应.随访1年,2组复发率被统计.治疗组有效率为84.4%,对照组有效率为57%.两组比较疗效差异有统计学意义.1年后脑梗死复发率治疗组为9.49%,对照组为21.05%.不良反应治疗组5例出现头晕,对照组4例出现腹胀,均未影响疗效.苦碟子联合华佗再造丸能改善脑梗死的治疗效果且耐受性好.表2,参5. To investigate the curative effect and safety with Ku Dei Zi plus Hua Tuo Recreative pills therapy in cerebral infarction. 150 cases cerebral infarction patients were randomly divided into contrast group(76 cases) and treatment group( 74 cases). Dei Zi Plus Hua Tuo Recreative pills were added in the treatment group. For the contrast group, general therapy was implemented. Both of the above groups, aspirin and nerves protection were needed. Nerve functional was evaluated respectively prior of the therapy and after 2 weeks treatment. Compared with the above two groups , the effective rate was 84.4% % of the treatment group and 57% of the contrast group( P 〈0.01 ). The recurrence rate was 9.49% of the treatment group and 21.05% of the contrast group after one year( P 〈 0.01 ). 5 cases of invalids in the treatment group appeared dizzy. 4 cases of patients in contrast group appeared abdomen swelling. But both of them can' t affect the curative effects. The combined therapy of Dei Zi and Hua Tuo Recreative pills might be effective and safe in the treatment of patients with cerebral infarction, and lowed the recurrence rate after one year. 2tabs. ,5refs.
出处 《湖南环境生物职业技术学院学报》 CAS 2008年第4期45-47,共3页 JOurnal of Hunan Environment Biological Polytechnic
关键词 苦碟子 华佗再造丸 脑梗死 复发率 Ku Dei Zi Hua Tuo Recreative pill cerebral infraction recurrence rate
  • 相关文献

参考文献2

二级参考文献8

  • 1Soriano SG, Coxon A, Wang YF, et al. Mice deficent in Mac-i(CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke, 1999,30(1):134-139.
  • 2Hagherg IA, Roald HE, Lyberg T. Adhesion of Ieukocytes to growing arterial thrombi. Thromb Haemost, 1998,80(5):852-858.
  • 3Esposito C J, Popescu WM, Rinder HM, et al, Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery, Thromb haemost, 2003,90(6): 1128-1134.
  • 4Tu L, Poe JC, Kadono T, et al. A functional role for circulating mouse L-selectin in regulating leukocyte/endothelial cell inter actions invivo. J Immunol, 2002,169(4):2034-2043.
  • 5Esposito C J, Popescu WM, Rinder HM, et al. Increased leukocyte-platelet adhesion in patients with graft ocusion after peripheral vascular surgery. Thromb Haemost, 2003,90(6): 1128-1134.
  • 6Coata G, Pennacchi L, Bini V, et al. Soluble adhesion molecules:Marker of pre-eclampsia and intrauterine growth restriction[J]. J Malern Fetal Neonatal Med, 2002,12(1):28-34.
  • 7Suwa T, Hogg JC, Quinlan KB, et al. The effect of in terleukin-6 on L-selection levels on polymorphonuclear leukocytes, Am J Physiol Heart circ Physiol, 2002,283(3):H879-884.
  • 8Min W, Bradley JR, Galbraith J J, et al. The N-terminal domains target TNF receptor-associated factor-2 to the nucleus and display transcription regulatory activity J Immunol. 1998,16(1):319.

共引文献33019

同被引文献69

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部